Comments
Loading...

Halozyme Therapeutics (HALO) Stock Price, Quote, News & History

HALONASDAQ
Logo brought to you by Benzinga Data
$63.55
0.0950.15%
Last update: Dec 16, 10:29 AM
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
60%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Analyst Trends and Forecast

1
Jul
3
1
Aug
2
Sep
3
2
Oct
1
1
Nov
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.1
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Key Statistics

Open
$63.24
Close
-
Volume / Avg.
193.32K / 2.35M
Day Range
$62.98 - $63.63
52 Wk Range
46.26 - 79.50
Market Cap
$7.43B
P/E Ratio
13.39
Dividend Yield
-
Exchange
NASDAQ
RSI
41
Short Interest
14.77%
Days to Cover
6.06

About

Sector
Health Care
Industry
Biotechnology
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary ...
Show More

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
HALO
IMVT

FAQ

Q

How do I buy Halozyme Therapeutics (HALO) stock?

A

You can purchase shares of Halozyme Therapeutics (NASDAQ:HALO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Halozyme Therapeutics (HALO) competitors?

Q

What is the forecast, or price target, for Halozyme Therapeutics (HALO) stock?

A

Halozyme Therapeutics has a consensus price target of $69.29.

Q

What is the current price for Halozyme Therapeutics (HALO)?

A

The stock price for Halozyme Therapeutics (NASDAQ: HALO) is $63.545 last updated December 16, 2025 at 10:29 AM EST.

Q

Does Halozyme Therapeutics (HALO) pay a dividend?

A

There are no upcoming dividends for Halozyme Therapeutics.

Q

When is Halozyme Therapeutics (NASDAQ:HALO) reporting earnings?

A

Halozyme Therapeutics does not have any upcoming earnings scheduled.

Q

Is Halozyme Therapeutics (HALO) going to split?

A

There is no upcoming split for Halozyme Therapeutics.

Q

What sector and industry does Halozyme Therapeutics (HALO) operate in?

A

Halozyme Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.